Ownership and insider activity for Thermo Fisher Scientific Inc. (TMO): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets.
Price
| Price | $676.76 |
| Market Cap | $250.2B |
| Exchange | NYSE |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-09-26 | WEISLER DION J | A-Award | 55 | |
| 2026-09-26 | SPERLING SCOTT M | A-Award | 62 | |
| 2026-09-26 | Lynch Karen S | A-Award | 46 | |
| 2026-09-26 | Keith R. Alexandra | A-Award | 46 | |
| 2026-09-26 | JOHNSON JENNIFER M | A-Award | 46 | |
| 2026-08-28 | CASPER MARC N | F-InKind | 724 | $451K |
| 2026-08-28 | CASPER MARC N | F-InKind | 531 | $331K |
| 2026-08-28 | Meyer James | F-InKind | 37 | $23K |
| 2026-08-28 | Meyer James | F-InKind | 44 | $28K |
| 2026-08-28 | Meyer James | F-InKind | 19 | $12K |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $786.0M | $1.33B | $2.10B | $2.40B | $10.32B | $4.48B | $8.52B | $8.08B | $4.02B | $9.85B |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $1.56B | $253.0M |
| Receivables | $3.05B | $3.88B | $4.59B | $4.95B | $6.47B | $8.95B | $9.43B | $9.66B | $9.63B | $10.57B |
| Inventory | $2.21B | $2.97B | $3.00B | $3.37B | $4.03B | $5.05B | $5.63B | $5.09B | $4.98B | $5.42B |
| Total Current Assets | $7.02B | $9.42B | $10.62B | $11.89B | $21.96B | $20.11B | $25.23B | $24.59B | $22.14B | $28.71B |
| Property, Plant & Equipment | $2.58B | $4.05B | $4.17B | $5.45B | $6.69B | $9.86B | $10.87B | $11.00B | $10.79B | $10.56B |
| Goodwill | $21.33B | $25.29B | $25.35B | $25.71B | $26.04B | $41.92B | $41.20B | $44.02B | $45.85B | $49.36B |
| Intangible Assets | $13.97B | $16.68B | $14.98B | $14.01B | $12.69B | $20.15B | $17.48B | $16.67B | $15.53B | $15.84B |
| Total Assets | $45.91B | $56.67B | $56.23B | $58.38B | $69.05B | $95.12B | $97.15B | $98.73B | $97.32B | $110.34B |
| Accounts Payable | $926.2M | $1.43B | $1.61B | $1.92B | $2.17B | $2.87B | $3.38B | $2.87B | $3.08B | $3.62B |
| Short-term Debt | $1.26B | $2.13B | $1.27B | $843.0M | $2.81B | $2.80B | $5.85B | $3.87B | $2.48B | $3.53B |
| Total Current Liabilities | $4.87B | $7.05B | $6.15B | $6.20B | $10.30B | $13.44B | $17.01B | $14.01B | $13.33B | $15.19B |
| Long-term Debt | $15.48B | $18.87B | $17.72B | $17.08B | $19.11B | $32.15B | $28.91B | $31.31B | $29.06B | $35.85B |
| Total Liabilities | $24.37B | $31.26B | $28.65B | $28.71B | $34.53B | $54.15B | $53.01B | $51.88B | $47.65B | $56.81B |
| Retained Earnings | $13.93B | $15.91B | $18.70B | $22.09B | $28.12B | $35.43B | $41.91B | $47.36B | $53.10B | $59.16B |
| Total Equity | $21.54B | $25.41B | $27.59B | $29.68B | $34.51B | $40.79B | $43.98B | $46.73B | $49.58B | $53.41B |
| Total Debt | $16.63B | $21.01B | $18.99B | $18.49B | $22.55B | $36.34B | $36.07B | $36.42B | $32.77B | $39.38B |
| Net Debt | $15.84B | $19.67B | $16.89B | $16.09B | $12.22B | $31.86B | $27.55B | $28.34B | $27.20B | $29.28B |
| Working Capital | $2.15B | $2.37B | $4.48B | $5.70B | $11.65B | $6.68B | $8.22B | $10.58B | $8.80B | $13.52B |
Financial Health
| Debt / Equity | 0.81 |
| Current Ratio | 1.55 |
| Piotroski F-Score | 5 |
| Altman Z-Score | 3.85 |
Profitability
| Return on Equity | 13.35% |
| Return on Invested Capital | 7.56% |
| Return on Assets | 6.17% |
| Gross Margin | 41.03% |
| Operating Margin | 17.97% |
| Net Margin | 15.06% |
Related companies: A · ABT · AMGN · AZN · DHR · IQV · ISRG
Explore sector: Healthcare · Medical - Diagnostics & Research
More sections of TMO: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks